⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3947642 | 0.62 | — | — | |
| SCHEMBL151530 | 0.62 | — | — | |
| SCHEMBL175266 | 0.59 | — | — | |
| SCHEMBL10639226 | 0.59 | — | — | |
| SCHEMBL441760 | 0.59 | — | — | |
| SCHEMBL387148 | 0.59 | — | — | |
| SCHEMBL18106367 | 0.59 | — | — | |
| SCHEMBL962488 | 0.59 | — | — | |
| SCHEMBL207783 | 0.59 | — | — | |
| SCHEMBL4831 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024068467-A1 | TETRAHYDROQUINOLINE COMPOUNDS AS ANTITUMOR AGENTS | COSCONATI SANDRO (IT) | 2024-04-04 | — | — | WO | claimed |
| EP-3538080-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LIKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | Hangzhou Dac Biotech Co. Ltd. (CN) | 2019-09-18 | — | — | EP | claimed |
| WO-2018086139-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LIKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2018-05-17 | — | — | WO | claimed |
| WO-2017051319-A1 | ARYL AND HETEROARYL ETHER COMPOUNDS AS ROR GAMMA MODULATORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2017-03-30 | — | — | WO | claimed |
| WO-2024140799-A1 | INHIBITORS OF KIF18A AND USES THEREOF | INSILICO MEDICINE IP LIMITED (CN) | 2024-07-04 | — | — | WO | disclosed |
| EP-4392071-A1 | METHOD OF SYNTHESIZING DENDRIMERIC AMPHIPHILE | Kaohsiung Medical University (TW) | 2024-07-03 | — | — | EP | disclosed |
| EP-4373836-A1 | COMPOUNDS AND COMPOSITIONS FOR TARGETED THERAPY OF RENAL DISEASES | Shanghai MicuRx Pharmaceutical Co., Ltd. (CN) | 2024-05-29 | — | — | EP | disclosed |
| EP-4347590-A1 | FUSED HETEROCYCLIC DERIVATIVES | Janssen Sciences Ireland Unlimited Company (IE) | 2024-04-10 | — | — | EP | disclosed |
| EP-4347594-A1 | 2, 8-DIAZASPIRO [4.5] DECANE COMPOUNDS | Genentech, Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| WO-2024068467-A1 | TETRAHYDROQUINOLINE COMPOUNDS AS ANTITUMOR AGENTS | COSCONATI SANDRO (IT) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024061300-A1 | INHIBITORS OF TREX1 AND USES THEREOF | INSILICO MEDICINE IP LIMITED (CN) | 2024-03-28 | — | — | WO | disclosed |
| CN-115246816-B | Double-target alogliptin derivative | 聊城大学 | 2024-03-26 | — | — | CN | disclosed |
| WO-2005000311-A1 | SUBSTITUTED DIKETOPIPERAZINES FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA | GLAXO GROUP LIMITED (GB) | 2005-01-06 | — | — | WO | disclosed |
| WO-2004105765-A1 | MACROCYCLIC QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2004-12-09 | — | — | WO | disclosed |
| EP-1458393-A1 | SUBSTITUTED DIKETOPIPERAZINES AS OXYTOCIN ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2004-09-22 | — | — | EP | disclosed |
| WO-2003053443-A1 | SUBSTITUTED DIKETOPIPERAZINES AS OXYTOCIN ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 2003-07-03 | — | — | WO | disclosed |
| EP-0332143-B1 | 11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] | KURARAY CO (JP) | 1994-03-16 | — | — | EP | disclosed |
| US-5278156-A | Steroids | KURARAY CO., LTD. (JP) | 1994-01-11 | — | — | US | disclosed |
| US-5015746-A | Esterification of prednisolone with 3,7,11-trimethyl-2,6,10-dodecatrienoic acid in the presence of disubstituted aminopyridines and a condensing agents | KURARAY CO., LTD. (JP) | 1991-05-14 | — | — | US | disclosed |
| EP-0332143-A1 | 11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] | KURARAY CO., LTD. (JP) | 1989-09-13 | — | — | EP | disclosed |